Literature DB >> 18483730

Receptor imaging of pediatric tumors: clinical practice and new developments.

Heike E Daldrup-Link1, Randall A Hawkins, Reinhard Meier, Robert E Goldsby, Dmitri Artemov.   

Abstract

Pediatric cancers often have specific molecular fingerprints making them primary candidates for the development of targeted imaging techniques. Tumor-targeted tracers have the potential to substantially advance the sensitivity and specificity of imaging techniques by improving tumor detection and characterization. This article reviews various approaches to target tumors via specific tumor antigens, tumor cell surface receptors and specific surface receptors of the endothelial cells of the tumor vessels. These new applied molecular imaging techniques are expected to improve our knowledge of the biology of pediatric cancers and, ultimately, to help in the development of tailored diagnoses and therapies, which may ultimately lead to better individual long-term outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483730     DOI: 10.1007/s00247-008-0878-x

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  36 in total

1.  Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe.

Authors:  Simonetta Geninatti Crich; Benedetta Bussolati; Lorenzo Tei; Cristina Grange; Giovanna Esposito; Stefania Lanzardo; Giovanni Camussi; Silvio Aime
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

2.  Effect of inhibition of vascular endothelial growth factor signaling on distribution of extravasated antibodies in tumors.

Authors:  Tsutomu Nakahara; Scott M Norberg; David R Shalinsky; Dana D Hu-Lowe; Donald M McDonald
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

3.  Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors.

Authors:  Jukka Vakkila; Ronald Jaffe; Marilyn Michelow; Michael T Lotze
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

4.  Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity.

Authors:  Eric J Werner; Stefano Avedano; Mauro Botta; Benjamin P Hay; Evan G Moore; Silvio Aime; Kenneth N Raymond
Journal:  J Am Chem Soc       Date:  2007-01-30       Impact factor: 15.419

5.  The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.

Authors:  Andrew Slack; Zaowen Chen; Roberto Tonelli; Martin Pule; Lisa Hunt; Andrea Pession; Jason M Shohet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-11       Impact factor: 11.205

6.  Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer.

Authors:  M R Feneley; H Jan; M Granowska; S J Mather; D Ellison; J Glass; M Coptcoat; R S Kirby; C Ogden; R T D Oliver; D F Badenoch; F I Chinegwundoh; V H Nargund; A M I Paris; K E Britton
Journal:  Prostate Cancer Prostatic Dis       Date:  2000-07       Impact factor: 5.554

Review 7.  Clinical relevance of molecular genetics to paediatric sarcomas.

Authors:  Olga Slater; Janet Shipley
Journal:  J Clin Pathol       Date:  2007-04-27       Impact factor: 3.411

8.  Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma.

Authors:  Andres Forero; Paul L Weiden; Julie M Vose; Susan J Knox; Albert F LoBuglio; Jordan Hankins; Michael L Goris; Vincent J Picozzi; Don B Axworthy; Hazel B Breitz; Robert B Sims; Richard G Ghalie; Sui Shen; Ruby F Meredith
Journal:  Blood       Date:  2004-03-02       Impact factor: 22.113

9.  Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

Authors:  Katherine K Matthay; Gregory Yanik; Julia Messina; Alekist Quach; John Huberty; Su-Chun Cheng; Janet Veatch; Robert Goldsby; Patricia Brophy; Leslie S Kersun; Randall A Hawkins; John M Maris
Journal:  J Clin Oncol       Date:  2007-03-20       Impact factor: 44.544

10.  Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.

Authors:  Patrick M Winter; Shelton D Caruthers; Andrea Kassner; Thomas D Harris; Lori K Chinen; John S Allen; Elizabeth K Lacy; Huiying Zhang; J David Robertson; Samuel A Wickline; Gregory M Lanza
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  2 in total

1.  Functional and molecular imaging with MRI: potential applications in paediatric radiology.

Authors:  Owen J Arthurs; Ferdia A Gallagher
Journal:  Pediatr Radiol       Date:  2010-10-23

2.  Target delivery of MYCN siRNA by folate-nanoliposomes delivery system in a metastatic neuroblastoma model.

Authors:  Qiqi Zhu; Chen Feng; Weiwei Liao; Yan Zhang; Suoqin Tang
Journal:  Cancer Cell Int       Date:  2013-06-27       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.